Christine Scott: Bard $5.5 Million Loss at Trial Survives Appeal

//Christine Scott: Bard $5.5 Million Loss at Trial Survives Appeal

Christine Scott: Bard $5.5 Million Loss at Trial Survives Appeal

aaBard Avaulta mesh miklos and mooreMesh maker C.R. Bard had challenged the jury award of $5.5 million for plaintiff Christine and Roy Scott in the first pelvic trial in the country in July 2012.

Now that jury decision has been upheld.  

The appellate opinion was issued by the California Court of Appeal, Fifth Appellate District in a unanimous opinion by a three judge panel. 

See the Opinion here.

The jury found Bard was negligent and awarded the Scotts $5.5 million with her surgeon, a nonparty, 40 percent at fault. The award was reduced accordingly. Scott was implanted with an Avaulta Plus mesh kit made by C.R. Bard.

Bard has the option to file a petition for review by the California Supreme Court, however there needs to be important legal issues that conflict in lower court rulings to merit a higher court review.

In its appeal, Bard argued that three negligence theories were erroneous in the matter of law and there was not enough substantial evidence to support the verdict. The Scotts argue the apportionment of part of the award to Scott’s surgeon was based on incorrect jury instructions.

The Opinion, granted November 19, affirms that Bard was not denied a fair trial and the Scotts had fair jury instructions. See the coverage in a Mesh News Desk story here.

Despite finding no manufacturing defect or failure to warn, the verdict was upheld on the negligence theory.  The trial appeared to be a wild one, with the plaintiff’s lawyer at one point going off on the judge, telling him Bard “owned the courthouse” and asking if he could please just have “a tiny bit of justice.”  There were also some colorful twitter posts by a juror during the trial (monitored by Bard) which led to Bard arguing for juror misconduct.

Another interesting issue was jury instructions.  The defendant doctor was an empty chair at trial.  The jury, amazingly, was not instructed on the standard of care for a physician, and in another odd twist, came back with a finding that the doctor’s negligence was not a substantial factor in plaintiff’s injuries and yet found him 40% at fault.  Nonetheless, the plaintiff was awarded $3.6 million in damages.


CS from the Bakersfield Californian

CS from the Bakersfield Californian

Christine Scott (CS) was implanted with a Bard Avaulta mesh kit by her gynecologist Dr. Tillaikaransi Kannappan who had received a one day training lab on the Avaulta taught by Susan Tate, a urogynecologist.

The training consisted or a powerpoint presentation and a cadaver lab.

Dr. Kannappan believed complications could be minimal and the Avaulta was safe to use.  She was not told Avaulta should not be used in women who are sexually active or for mild prolapse.

Scott had incontinence while participating in sports and mild pelvic prolapse of the bladder and rectum.   As a treatment, in January 2008 Dr. Kannappan implanted a mesh sling and two Avaulta Plus mesh kits one for anterior one for posterior.  Dr. Kannappan says she did not read the instructions for use on the Avaulta plus but did watch a DVD on the surgical technique about a week before Scott’s surgery.

What followed were eight surgeries to resolve urination blockage and mesh erosion into the rectum. CS has pain, nerve damage and incontinence. The complaint included negligence, strict product liability, negligent misrepresentation and fraud against Bard as well as Dr. Kannappan and another surgeon Dr. Klis. That latter action was dismissed.

One expert in the case, Dr. Donald Ostergard testified that the surgical technique used in Scott’s surgery and the one day Avaulta training did not meet the requisite standard of care expected of a practicing physician in ob-gyn in Bakersfield, California.

The jury awarded CS $5 million in damages and her husband $500,000 for loss of consortium. Of that award Dr. Kannappan was assigned $3.31 million for CS and $300,000 for her husband, Roy.

During the trial proceedings the judge considered filing contempt charges against Eugene Lorenz for comments made in open court out of the earshot of the jury (Page 26). Page 28 contains statements made by Juror 14 before the trial was concluded on Twitter.

Bard did not bring this issue to the Courts attention during the trial so forgoes seeking a new trial on the ground of juror impropriety.     #

By | 2016-09-07T04:52:41+00:00 November 20th, 2014|Legal News|13 Comments

About the Author:

I’m National News Editor, Jane Akre and I began Mesh Medical Device News Desk aka Mesh News Desk (MND) in the summer of 2011 just after the Food and Drug Administration issued an explicit warning to the public that complications associated with surgical mesh used for prolapse repair (POP) and incontinence (SUI) are NOT rare! That was the starting point for the litigation you see today and thousands of lawsuits have been filed by women whose lives have been altered, some permanently, by the use of this petroleum-based product.


  1. Jan Urban November 20, 2014 at 3:31 pm - Reply

    So this is good news that the appeals do not have a leg to stand on.

  2. Lisa Terry November 20, 2014 at 7:30 pm - Reply

    this is awesome I hope we all win our cases I to have a BARD MESH.

  3. jacqui scott November 20, 2014 at 10:46 pm - Reply

    Well Done Christine <3

  4. jacqui scott November 20, 2014 at 10:49 pm - Reply

    So Glad You Stayed Strong Christine My Love And Prayers Are With You Akways Miss You

  5. Diane November 21, 2014 at 2:02 am - Reply

    So happy for you and your husband, Christine!!!! You deserve every penny and more…love and hugs to you!!!!

  6. Jemima williams November 21, 2014 at 3:21 am - Reply

    Congratulations to Christine and Roy!

    I’m so glad that you have both stayed so strong throughout all of this. No amount of compensation can ever bring back what you have both lost, but I pray for a wonderful less-pain future for you <3

    Much love and many blessings to you both!

  7. Noreen Wideman November 21, 2014 at 10:35 am - Reply

    congratulations Christine and Roy ! so glad you two have been leading the way for accountability !! bless you both for speaking out and encouraging our voices to rise above the deaf ears of much of the medical community and the white noise of manufacturers trying to drown out our voices with their well funded pervasive marketing …..

  8. Evy. November 21, 2014 at 12:11 pm - Reply

    This is Great news .. 🙂

  9. msm November 21, 2014 at 7:15 pm - Reply

    I think Bard should have to pay interest on every penny for every day it took for that appeal. That might lessen the temptation to appeal on frivolous grounds. Let them pay a sizeable penalty to the court as well. Seems fair to me. Win the appeal – no penalty. Lose it – pay up.

    Similar to the NFL challenge procedure. A coach can throws his red flag to challenge the call, but if video confirms the call, the coach is penalized.

    Why the heck isn’t there a penalty when dealing with peoples lives who have suffered too much already.

    • Pat November 21, 2014 at 9:14 pm - Reply

      I agree!

  10. Linda h November 30, 2014 at 7:56 pm - Reply

    So very happy for you Christine. Hopefully the money that you eventually get lessons your physical burdens in someway. You deserve every penny for what you have endured and will endure from this cruel and inhumane injustice.

  11. Mally June 27, 2017 at 10:39 pm - Reply

    Good. My mother has had numerous surgeries because of this. Many stays in the hospital. So much damage on all levels. I hope this company pays for the lives they’ve ruined. This is not the first time they have done something like this. Why are they still around?

    • Jane Akre June 29, 2017 at 12:07 pm - Reply

      Because a profitable medical device always get the benefit of the doubt in my opinion. But you ask a good question.

Leave A Comment